Showing results 48 to 67 of 83
< previous
next >
| Issue Date | Title | Author(s) |
| 2020-03-10 | Nanomedicine advances in cancer therapy | Hinge, N; Pandey, MM; Singhvi, G; Gupta, G; Mehta, M; Satija, S; Gulati, M; Dureja, H; Dua, K |
| 2021-01-01 | Nanosuspensions - An Update on Recent Patents, Methods of Preparation, and Evaluation Parameters. | Khanuja, HK; Awasthi, R; Mehta, M; Satija, S; Aljabali, AA; Tambuwala, MM; Chellappan, DK; Dua, K; Dureja, H |
| 2021-10-01 | Nanotechnology based advanced therapeutic strategies for targeting interleukins in chronic respiratory diseases. | Hussain, MS; Sharma, P; Dhanjal, DS; Khurana, N; Vyas, M; Sharma, N; Mehta, M; Tambuwala, MM; Satija, S; Sohal, SS; Oliver, BGG; Sharma, HS |
| 2020-01-18 | Obesity and Diabetes: Pathophysiology of Obesity-Induced Hyperglycemia and Insulin Resistance | Gupta, G; Wadhwa, R; Pandey, P; Singh, SK; Gulati, M; Satija, S; Mehta, M; Singh, AK; Dureja, H; Collet, T; Pabreja, K; Chellappan, DK; Dua, K |
| 2019-08-01 | Oligonucleotide therapy: An emerging focus area for drug delivery in chronic inflammatory respiratory diseases | Mehta, M; Deeksha; Tewari, D; Gupta, G; Awasthi, R; Singh, H; Pandey, P; Chellappan, DK; Wadhwa, R; Collet, T; Hansbro, PM; Kumar, SR; Thangavelu, L; Negi, P; Dua, K; Satija, S |
| 2020-12-01 | Overcoming the dissolution rate, gastrointestinal permeability and oral bioavailability of glimepiride and simvastatin co-delivered in the form of nanosuspension and solid self-nanoemulsifying drug delivery system: A comparative study | Pandey, NK; Singh, SK; Gulati, M; Kumar, B; Kapoor, B; Ghosh, D; Kumar, R; Khursheed, R; Awasthi, A; Kuppusamy, G; Wadhwa, S; Satija, S; Dureja, H; Jain, SK; Chellappan, DK; Anand, K; Mehta, M; Dua, K |
| 2020-06-16 | Oxidative Stress and Immunological Complexities in Multidrug-Resistant Tuberculosis | Wadhwa, R; Sehgal, N; G, N; Aggarwal, T; Satija, S; Mehta, M; Gupta, G; Chellappan, DK; Tambuwala, MM; Oliver, B; Collet, T; Maurya, PK; Hansbro, PM; Dua, K |
| 2020-01-01 | Oxidative stress in neurology and in neurodegenerative processes | Gupta, G; Pathak, S; Rawat, S; Mishra, A; Singh, Y; Mehta, M; Satija, S; Khurana, N; De Jesus Andreoli Pinto, T; Shukla, S; Pabreja, K; Chellappan, DK |
| 2020-05 | Patented therapeutic drug delivery strategies for targeting pulmonary diseases. | Thakur, AK; Chellappan, DK; Dua, K; Mehta, M; Satija, S; Singh, I |
| 2021 | Perfluorocarbons Therapeutics in Modern Cancer Nanotechnology for Hypoxiainduced Anti-tumor Therapy. | Satija, S; Sharma, P; Kaur, H; Dhanjal, DS; Chopra, RS; Khurana, N; Vyas, M; Sharma, N; Tambuwala, MM; Bakshi, HA; Charbe, NB; Zacconi, FC; Chellappan, DK; Dua, K; Mehta, M |
| 2020-08-06 | Perspectives and advancements in the design of nanomaterials for targeted cancer theranostics. | Tan, YY; Yap, PK; Xin Lim, GL; Mehta, M; Chan, Y; Ng, SW; Kapoor, DN; Negi, P; Anand, K; Singh, SK; Jha, NK; Lim, LC; Madheswaran, T; Satija, S; Gupta, G; Dua, K; Chellappan, DK |
| 2022-05 | Pharmacological evaluation of bromelain in mouse model of Alzheimer's disease. | Kumar, R; Kumar, R; Sharma, N; Khurana, N; Singh, SK; Satija, S; Mehta, M; Vyas, M |
| 2022-04-25 | Pharmacological Properties of Bergapten: Mechanistic and Therapeutic Aspects | Quetglas-Llabrés, MM; Quispe, C; Herrera-Bravo, J; Catarino, MD; Pereira, OR; Cardoso, SM; Dua, K; Chellappan, DK; Pabreja, K; Satija, S; Mehta, M; Sureda, A; Martorell, M; Satmbekova, D; Yeskaliyeva, B; Sharifi-Rad, J; Rasool, N; Butnariu, M; Bagiu, IC; Bagiu, RV; Calina, D; Cho, WC |
| 2020-08-17 | Plant-based drug delivery systems in respiratory diseases | Mehta, M; Sharma, P; Kaur, S; Dhanjal, DS; Singh, B; Vyas, M; Gupta, G; Chellappan, DK; Nammi, S; Singh, TG; Dua, K; Satija, S; Dua, K; Hansbro, P; Wadhwa, R; Haghi, M; Pont, L; Williams, K |
| 2020-05-04 | Plants derived therapeutic strategies targeting chronic respiratory diseases: Chemical and immunological perspective. | Prasher, P; Sharma, M; Mehta, M; Paudel, KR; Satija, S; Chellappan, DK; Dureja, H; Gupta, G; Tambuwala, MM; Negi, P; Wich, PR; Hansbro, NG; Hansbro, PM; Dua, K |
| 2020-11-06 | Potential Anti-epileptic Phytoconstituents: An Updated Review. | Kaur, J; Famta, P; Famta, M; Mehta, M; Satija, S; Sharma, N; Vyas, M; Khatik, GL; Chellappan, DK; Dua, K; Khurana, N |
| 2019-09-01 | The potential of siRNA based drug delivery in respiratory disorders: Recent advances and progress | Dua, K; Wadhwa, R; Singhvi, G; Rapalli, V; Shukla, SD; Shastri, MD; Gupta, G; Satija, S; Mehta, M; Khurana, N; Awasthi, R; Maurya, PK; Thangavelu, L; Rajeshkumar, S; Tambuwala, MM; Collet, T; Hansbro, PM; Chellappan, DK |
| 2020-07-30 | Probing 3CL protease: Rationally designed chemical moieties for COVID-19. | Sharma, M; Prasher, P; Mehta, M; Zacconi, FC; Singh, Y; Kapoor, DN; Dureja, H; Pardhi, DM; Tambuwala, MM; Gupta, G; Chellappan, DK; Dua, K; Satija, S |
| 2021-10-15 | Protein and peptide delivery to lungs by using advanced targeted drug delivery. | Chellappan, DK; Prasher, P; Saravanan, V; Vern Yee, VS; Wen Chi, WC; Wong, JW; Wong, JK; Wong, JT; Wan, W; Chellian, J; Molugulu, N; Prabu, SL; Ibrahim, R; Darmarajan, T; Candasamy, M; Singh, PK; Mishra, V; Khurana, N; Shastri, MD; Satija, S; Zacconi, FC; Chakraborty, A; Mehta, M; Gupta, PK; Dureja, H; Gulati, M; Singh, SK; Gupta, G; Jha, NK; George Oliver, BG; Dua, K |
| 2020-05-02 | RAAS blockers in hypertension posing a higher risk toward the COVID-19. | Singh, Y; Gupta, G; Satija, S; Negi, P; Chellappan, DK; Dua, K |
